Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy.
Improving the efficacy of standard chemotherapy by targeting DNA repair mechanisms remains an important area of research. O6-methylguanine-DNA-methyltransferase (MGMT), which repairs alkylating agent damage, is one such target. Downregulation of the gene through epigenetic silencing has been shown t...
Main Authors: | Sabharwal, A, Middleton, MR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Inhibition of O-6-methylguanine DNA methyltransferase (MGMT) in solid tumors by lomeguatrib
by: Sabharwal, A, et al.
Published: (2008) -
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.
by: McCormack, A, et al.
Published: (2009) -
Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib.
by: Watson, A, et al.
Published: (2010) -
Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells.
by: Sabharwal, A, et al.
Published: (2011) -
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
by: Watson, A, et al.
Published: (2009)